All filters
Videos
Dual Regimen – Considerations For Key Populations/Adolescence - Victor Musiime, MBChB, MMed, PhD
Presented at:
African HIV Clinical Forum 2022
Videos
Dual Regimen – Is That the Future For Africa? - François Venter, MD, FCP, PhD
Presented at:
African HIV Clinical Forum 2022
Videos
Dual Regimen – What Are The Clinical Trials Data - Michelle Venter, MBBCh, FCP, MMed
Presented at:
African HIV Clinical Forum 2022
Videos
Dual Regimen – What Are the Resistance Considerations - Ricardo Diaz, MD
Presented at:
African HIV Clinical Forum 2022
Videos
HIV Prevention – During COVID Pandemic - Andrew Mujugira, MBChB, MSc, MPH, PhD, MACE
Presented at:
African HIV Clinical Forum 2022
Videos
HIV Prevention – Role of Long Acting ARVs - Nyaradzo Mavis Mgodi, MBChB, MMed
Presented at:
African HIV Clinical Forum 2022
Videos
HIV Prevention – Make It Happen in Africa - Nomathemba Chandiwana, BSc, MBBCh, MPH, DCH
Presented at:
African HIV Clinical Forum 2022
Videos
Rapid Start – In Practice Clinical Case - Francis Ssali, MBChB
Presented at:
African HIV Clinical Forum 2022
Videos
Rapid Start – Is It Feasible? - Remco Peters, MD, PhD
Presented at:
African HIV Clinical Forum 2022
Slidesets
Victor Musiime, MBChB, MMed, PhD - Dual Regimen – Considerations For Key Populations: Adolescence
Presented at:
African HIV Clinical Forum 2022
Slidesets
Francis Ssali, MBChB - Rapid Start – In Practice: Clinical Case
Presented at:
African HIV Clinical Forum 2022
Abstracts
HIV-1 Integrase Resistance Associated Mutations and the Use of Dolutegravir in Sub- Saharan Africa: A Systematic Review and Meta-Analysis
E. Semengue
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV transmission clusters in Europe: A perspective view of Late presenters and Non-Late presenters
Mafalda N.S. Miranda
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Characterization of SARS-CoV-2 epidemic and transmission dynamics in children over the four COVID-19 waves
R. ScutariÂ
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing
M. Bellocchi
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
SARS-CoV-2 mutations and variants may muddle the sensitivity of COVID-19 diagnostic assays
M. Alkhatib
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies
L. Fiaschi
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Levels and durability of humoral and T-specific responses after the booster dose of mRNA BNT162b2 vaccine in residents of a Long Term Care Facility
A. Bergna
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Transmitted drug resistance to integrase based first-line treatment in Europe, 2018-2021
F. Garcia
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV-1 Transmitted drug resistance and transmission clusters in newly diagnosed patients in Portugal between 2014 and 2019
M. Pingarilho
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Reaching the 95-95-95 targets will not eliminate HIV transmission in 2030 among individuals born in sub-Saharan Africa residing in the Netherlands
S. Mukherjee
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV reservoir quantification by combining total HIV-1 DNA assay and intact proviral DNA assay (IPDA) in one triplex digital PCR reaction
M. Delporte
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Temporal trend of drug- resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals
D. Armenia
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Comparison of Markers of Inflammation and Associated Baseline Variables in Virologically Suppressed Participants in the TANGO Study at Week 144
R. Wang
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022